Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man
✍ Scribed by Andrés F. Henao-Martínez; Adriana Weinberg; W. James Waldman; Marilyn E. Levi
- Book ID
- 116632316
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 154 KB
- Volume
- 54
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Aciclovir (ACV)‐resistant __Herpes simplex virus__ type‐2 (HSV‐2) infections are observed commonly in patients also infected with HIV‐1. The use of foscarnet (FOS) in these patients may also lead to resistance. This situation can become a difficult therapeutic challenge. Four cases of p
An HIV-1 infected immunosuppressed patient (CD4+ cell counts: 382 cells/microL; viral load 94,000 copies/mL) with recurrent perianal herpes simplex virus type 2 (HSV-2) infections is described, showing an unusual exophytic tumour resembling a squamous cell carcinoma in the lateral part of the tongue
A human leukocyte antigen (HLA)-matched unrelated bone marrow transplantation (BMT) was performed in a 13-year-old patient with the congenital immunodeficiency syndrome, Wiskott-Aldrich syndrome. The patient had a history of acyclovir (ACV)-resistant (ACV(r)) herpes simplex virus type 1 (HSV-1) infe